Identification of autoantibodies associated with myelin damage in multiple sclerosis

Nature Medicine

Volumn 5, Issue 2, 1999, Pages 170-175

  Genain, Claude P ^a   Cannella, Barbara ^b   Hauser, Stephen L ^a   Raine, Cedric S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MYELIN;

ALLERGIC ENCEPHALOMYELITIS; ANTIBODY DETECTION; ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMBRANE DAMAGE; MICROSCOPY; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; TARGET ORGAN;

ANIMALS; AUTOANTIBODIES; CALLITHRIX; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON; MULTIPLE SCLEROSIS; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN;

MARMOSETS;

EID: 0032950794     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/5532     Document Type: Article

References (35)

1. Brosnan, C.F. & Raine, C.S. Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6, 243-257 (1996).
2. Hohlfeld, R. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain 120, 865-916 (1997).
3. Wekerle, H., Linington, C., Lassmann, H. & Meyermann, R. Cellular immune reactivity within the CNS. Trends Neurosci. 9, 271-277 (1986).
4. Willenborg, D.O. & Prowse, S.J. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis. J. Neuroimmunol. 5, 99-109 (1983).
5. Piddlesden, S.J., Lassmann, H., Zimprich, F., Morgan, B.P. & Linington, C. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143, 555-564 (1993).
6. Wolf, S., Dittel, B., Hardardottir, F. & Janeway, C.J. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184, 2271-2278 (1996).
7. Raine, C.S. & Bornstein, M.B. Experimental allergic encephalomyelitis: an ultrastructural study of demyelination in vitro. J. Neuropathol. Exp. Neurol. 29, 177-191 (1970).
8. Raine, C.S., Hummelgard, A., Swanson, E. & Bornstein, M.B. Multiple sclerosis: serum-induced demyelination in vitro. A light and electron microscope study. J. Neurol. Sci 20, 127-148 (1973).
9. Genain, C.P. et al. Antibody facilitation of multiple sclerosis-like lesions in a non human primate. J. Clin. Invest. 96, 2966-2974 (1995).
10. Kirschner, D.A. & Blaurock, A.E. in Myelin: Biology and Chemistry (ed. Martenson, R.E.) 3-78 (CRC, Boca Raton, Florida, 1992).
11. Brunner, C., H. Lassman, Waehneldt, T.V., Matthieu, J.M. & Linington, C. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2′3′ cyclic nucleotide phosphodiesterase in the CNS of adult rats. J. Neurochem. 52, 296-304 (1989).
12. Lassmann, H., Brunner, C., Bradl, M. & Linington, C. Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol. (Berl) 75, 566-576 (1988).
13. Takisawa, T. & Robinson, J.M. Use of 1.4-nm immunogold particles for immunocytochemistry on ultra-thin-cryo-sections. J. Histochem. Cytochem. 43, 1615-1623 (1994).
14. Genain, C.P. et al. Late complications of immune deviation therapy in a non human primate. Science 274, 2054-2057 (1996).
15. Tabira, T. & Kira, J.-I. in Myelin: Biology and Chemistry (ed. Martenson, R.E.) 783-799 (CRC, Boca Raton, Florida, 1992).
16. Warren, K.G., Catz, I. & Steinman, L. Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B cell epitope and a model of its features. Proc. Natl. Acad. Sci. USA 92, 11061-11065 (1995).
17. Raine, C.S., Snyder, D.H., Valsamis, M.P. & Stone, S.H. Chronic experimental allergic encephalomyelitis in inbred guinea pigs. An ultrastructural study. Lab. Invest. 31, 369-380 (1974).
18. Dal Canto, M.C., Wisniewski, H.M., Johnson, A.B., Brostoff, S.W. & Raine, C.S. Vesicular disruption of myelin in autoimmune demyelination. J. Neurol. Sci. 24, 313-319 (1975).
19. Seil, F.J., Falk, G.A., Kies, M.W. & Alvord, E.C. The in vitro demyelinating activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogen. Exp. Neurol. 22, 545-555 (1968).
20. Raine, C.S., Johnson, A.B., Marcus, D.M., Suzuki, A. & Bornstein, M.B. Demyelination in vitro. Absorption studies demonstrate that galactocerebroside is a major target. J. Neurol. Sci. 52, 117-131 (1981).
21. Brosnan, C.F., Traugott, U. & Raine, C.S. Analysis of humoral and cellular events and the role of lipid haptens during CNS demyelination. Acta Neuropathol. (Berlin) Suppl. 9, 59-70 (1983).
22. Linington, C. & Lassmann, H. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J. Neuroimmunol 17, 61-69 (1987).
23. Gerritse, K. etal. The involvement of specific anti myelin basic protein antibody-forming cells in multiple sclerosis immunopathology. J. Neuroimmunol. 49, 153-159 (1994).
24. Sun, J. et al. T and B cell responses to myelin oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146, 1490-1495 (1991).
25. Benveniste, E.N. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 75, 165-173 (1997).
26. Morris, G. in Epitope mapping protocols 1-416 (Humana Press, Totowa, 1996).
27. Amor, S. et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153, 4349-4356 (1994).
28. Ichikawa, M., Johns, T.G., Liu, J. & Bernard, C.C.A. Analysis of the fine B-cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. J. Immunol 157, 919-926 (1996).
29. Lassmann, H., Raine, C.S., Antel, J. & Prineas, J. Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J. Neuroimmunol. 86, 213-217 (1998).
30. Aleu, F.P., Katzman, R. & Terry, R.D. Fine structure and electrolyte analysis of cerebral edema induced by alkyl-tin intoxication. J. Neuropath. Exp. Neurology 22, 403-(1963).
31. Compston, A., Scolding, N., Wren, D. & Noble, M. The pathogenesis of demyelinating disease: insights from cell biology. Trends Neurosci. 14, 175-182 (1991).
32. Prineas, J.W. & Connell, F. The fine structure of chronically active multiple sclerosis plaques. Neurology 28, 68-75 (1978).
33. Epstein, L.G., Prineas, J.W. & Raine, C.S. Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis. J. Neurol. Sci. 61, 341-348 (1983).
34. Moore, G.R.W. & Raine, C.S. Immunogold localization and analysis of IgC during immune-mediated demyelination. Lab. Invest. 59, 641-648 (1988).
35. Pham-Dinh, D. et al. Characterization and expression of the cDNA coding for the human myelin/oligodendrocyte glycoprotein. J. Neurochem. 63, 2353-2356 (1994).